These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 27496519)

  • 1. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology.
    Wesolowski AM; Zaccagnino MP; Malapero RJ; Kaye AD; Urman RD
    Pharmacotherapy; 2016 Sep; 36(9):1021-7. PubMed ID: 27496519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.
    Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T
    Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remimazolam for anaesthesia or sedation.
    Sneyd JR; Rigby-Jones AE
    Curr Opin Anaesthesiol; 2020 Aug; 33(4):506-511. PubMed ID: 32530890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.
    Rogers WK; McDowell TS
    IDrugs; 2010 Dec; 13(12):929-37. PubMed ID: 21154153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent.
    Kim SH; Fechner J
    Korean J Anesthesiol; 2022 Aug; 75(4):307-315. PubMed ID: 35585830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remimazolam: A Review in Procedural Sedation.
    Lee A; Shirley M
    Drugs; 2021 Jul; 81(10):1193-1201. PubMed ID: 34196946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
    Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K
    Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice.
    Masui K
    Curr Opin Anaesthesiol; 2024 Aug; 37(4):344-351. PubMed ID: 38841907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.
    Pedersen MH; Danø A; Englev E; Kattenhøj L; Munk E
    Curr Med Res Opin; 2023 May; 39(5):691-699. PubMed ID: 36999319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.
    Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K
    Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of remimazolam tosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial.
    Zhu H; Su Z; Huai X; Chen C; Zhang X; Zhou J; Su D
    Trials; 2022 Dec; 23(1):995. PubMed ID: 36510290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent.
    Kilpatrick GJ
    Front Pharmacol; 2021; 12():690875. PubMed ID: 34354587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
    Rex DK; Bhandari R; Desta T; DeMicco MP; Schaeffer C; Etzkorn K; Barish CF; Pruitt R; Cash BD; Quirk D; Tiongco F; Sullivan S; Bernstein D
    Gastrointest Endosc; 2018 Sep; 88(3):427-437.e6. PubMed ID: 29723512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia.
    Dai G; Pei L; Duan F; Liao M; Zhang Y; Zhu M; Zhao Z; Zhang X
    Minerva Anestesiol; 2021 Oct; 87(10):1073-1079. PubMed ID: 34263581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of intranasal remimazolam-a randomized controlled clinical trial.
    Pesic M; Schippers F; Saunders R; Webster L; Donsbach M; Stoehr T
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1505-1516. PubMed ID: 32886178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and maintenance of procedural sedation in adults: focus on remimazolam injection.
    Chen W; Chen S; Huang Y
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):411-426. PubMed ID: 33686920
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant Users.
    Schippers F; Pesic M; Saunders R; Borkett K; Searle S; Webster L; Stoehr T
    J Clin Pharmacol; 2020 Sep; 60(9):1189-1197. PubMed ID: 32495449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.